BofA raised the firm’s price target on Exelon (EXC) to $50 from $48 and keeps a Neutral rating on the shares. The firm, which expects Exelon to report Q3 operating earnings of 78c, versus consensus expectations of 76c per share, also expects the company will reaffirm its FY25 EPS guidance of $2.64-$2.74, the analyst tells investors in a preview.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXC:
- Exelon Hold Rating: Stability Amid Regulatory Proceedings and Updated Valuation
- Exelon price target raised to $50 from $48 at UBS
- Exelon: Strong Regulatory Environment and Growth Prospects Justify Buy Rating
- Exelon initiated with an Outperform at Evercore ISI
- Exelon: Strategic Growth and Attractive Risk-Return Profile Amidst Regulatory Clarity